Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Alpine Immune Sciences Inc sell mixitrader

Start price
€3.88
15.09.19 / 50%
Target price
€0.000
02.10.19
Performance (%)
-14.44%
End price
€3.32
02.10.19
Summary
This prediction ended on 02.10.19 with a price of €3.32. The prediction for Alpine Immune Sciences Inc closed with a convincing performance of -14.44%. mixitrader has 50% into this prediction

Alpine Immune Sciences is a clinical-stage biotechnology company focused on developing novel therapies that modulate the immune system to treat cancer, autoimmune, and inflammatory diseases. The company's proprietary platform technology, called "Variant Ig Domain" (vIgD), enables the design and development of unique protein therapeutics that can target specific immune cells and pathways. Alpine's lead product candidate, ALPN-202, is a dual ICOS/CD28 antagonist for the treatment of autoimmune and inflammatory diseases, and the company has several other product candidates in preclinical development. Alpine Immune Sciences is listed on the NASDAQ stock exchange under the ticker symbol "ALPN".

Performance without dividends (%)
Name 1w 1m 1y 3y
Alpine Immune Sciences Inc -3.261% -3.261% 384.683% 278.723%
iShares Core DAX® 2.149% 5.415% 21.385% 22.595%
iShares Nasdaq 100 0.838% 1.926% 44.386% 55.330%
iShares Nikkei 225® 1.143% 2.887% 27.641% 9.481%
iShares S&P 500 1.265% 3.698% 33.327% 49.646%

Comments by mixitrader for this prediction

In the thread Alpine Immune Sciences Inc diskutieren

Sell mit Kursziel 0,0

Prediction Sell
Perf. (%) -14.44%
Target price 0.000
Change
Ends at 02.10.19

Sell beendet